17β-estradiol inhibits tumor necrosis factor-α-induced nuclear factor-κB activation by increasing nuclear factor-κB p105 level in MCF-7 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 279, Issue 1, 2000, Pages 47-52

  Hsu, Su Ming ^a   Chen, Yen Chou ^b   Jiang, Ming Chung ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

Author keywords

17 estradiol; 4OH tamoxifen; I B ; MCF 7 breast cancer cells; NF B; NF B p105; Nuclear translocation; TNF

Indexed keywords

4 HYDROXYTAMOXIFEN; DNA; ESTRADIOL; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P105; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034627130     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3891     Document Type: Article

References (46)

1. Recent advances in the molecular basis of TNF signal transduction
2. The NF-kappa B and I kappa B proteins: New discoveries and insights
3. The history, properties, and biological effects of cachectin
4. Two TNF receptors
5. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex
6. I kappa B: A specific inhibitor of the NF-kappa B transcription factor
7. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B
8. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit
9. Inactivation of NF-κ B inhibitor I κ B α: Ubiquitin-dependent proteolysis and its degradation product
10. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway
11. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
12. A glycine-rich region in NF-kappa B p105 functions as a processing signal for the generation of the p50 subunit
13. The precursor of NF-kappa B p50 has I kappa B-like functions
14. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50
15. Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3
16. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction
17. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs
18. Steroid-hormone receptors in breast cancer
19. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells
20. Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone sulfate to estradiol in the MCF-7 mammary cancer cell line
21. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations
22. NF-kappa B precursor pl00 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors
23. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule
24. Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B
25. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells
26. Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/ MAD3
27. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta
28. The value of estrogen and progesterone receptors in the treatment of breast cancer
29. Estrogen receptor variants in clinical breast cancer
30. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor
31. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens
32. Estradiol down-regulates LPS-induced cytokine production and NF-kappa B activation in murine macrophages
33. Constitutive activation of NF-kappa B during progression of breast cancer to hormone-independent growth
34. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta
35. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor
36. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation
37. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex
38. Cloning of the DNA-binding subunit of human nuclear factor kappa B: The level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha
39. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappa B
40. Regulation of death promoter Bak expression by cell density and 17 beta-estradiol in MCF-7 cells
41. 17β-estradiol inhibits apoptosis of endothelial cells
42. 17β-estradiol prevents programmed cell death in cardiac myocytes
43. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells
44. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages
45. Estrogens, the immune response and autoimmunity
46. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages